Abbvie Inc
NYSE:ABBV
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
137.6
199.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ABBV stock under the Base Case scenario is hidden USD. Compared to the current market price of 187.88 USD, Abbvie Inc is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Abbvie Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ABBV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Sign up to unlock intrinsic valuation and risk & rewards analysis.
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
AbbVie Inc. is a global biopharmaceutical company that emerged from Abbott Laboratories in 2013, establishing itself as a key player in the healthcare sector with a strong focus on developing innovative therapies. Headquartered in North Chicago, Illinois, AbbVie specializes in immunology, oncology, neuroscience, and virology, boasting a diverse portfolio of products designed to address complex health challenges. Its flagship drug, Humira, has been a cornerstone of the company’s success, contributing significantly to its revenues since it was launched. However, with the expiration of Humira's patent, AbbVie is strategically transitioning its focus toward new treatments, including promising dr...
Revenue & Expenses Breakdown
Abbvie Inc
Balance Sheet Decomposition
Abbvie Inc
Current Assets | 33.8B |
Cash & Short-Term Investments | 13.2B |
Receivables | 11.7B |
Other Current Assets | 8.9B |
Non-Current Assets | 108.1B |
Long-Term Investments | 272m |
PP&E | 5B |
Intangibles | 93.6B |
Other Non-Current Assets | 9.2B |
Current Liabilities | 41.9B |
Accounts Payable | 29.3B |
Other Current Liabilities | 12.6B |
Non-Current Liabilities | 93.2B |
Long-Term Debt | 58B |
Other Non-Current Liabilities | 35.2B |
Earnings Waterfall
Abbvie Inc
Revenue
|
55B
USD
|
Cost of Revenue
|
-18.3B
USD
|
Gross Profit
|
36.7B
USD
|
Operating Expenses
|
-20.6B
USD
|
Operating Income
|
16B
USD
|
Other Expenses
|
-10.7B
USD
|
Net Income
|
5.3B
USD
|
Free Cash Flow Analysis
Abbvie Inc
USD | |
Free Cash Flow | USD |
AbbVie surpassed expectations with adjusted earnings per share of $2.65 and net revenues of nearly $14.5 billion, reflecting a robust growth of 5.6%. This strong performance led to an upward revision in annual guidance, raising expected earnings per share to between $10.71 and $10.91 and total net revenues to approximately $55.5 billion. Key drivers include more than 18% sales growth from the ex-HUMIRA platform, with notable increases in SKYRIZI, Rinvoq, and Venclexta sales. Despite challenges in aesthetics, particularly in the U.S. and China, confidence remains high due to low market penetration and upcoming product launches【4:0†source】【4:1†source】【4:4†source】.
What is Earnings Call?
ABBV Profitability Score
Profitability Due Diligence
Abbvie Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Abbvie Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
ABBV Solvency Score
Solvency Due Diligence
Abbvie Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Abbvie Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 205.97 USD with a low forecast of 171.7 USD and a high forecast of 236.25 USD.
Dividends
Current shareholder yield for ABBV is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ABBV Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 50,000 full-time employees. The company went IPO on 2013-01-02. The firm is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The firm's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Contact
IPO
Employees
Officers
The intrinsic value of one ABBV stock under the Base Case scenario is hidden USD.
Compared to the current market price of 187.88 USD, Abbvie Inc is hidden .